Elaine T. Lam

5.9k citations
119 papers · 1.8k indexed · h-index 18
Topics
Renal cell carcinoma treatment (47 papers)Cancer Immunotherapy and Biomarkers (22 papers)Prostate Cancer Treatment and Research (19 papers)

In The Last Decade

Elaine T. Lam

109 papers receiving 1.7k citations

Peers

Elaine T. Lam
Comparison fields: 5 of 97
  • Oncology 677
  • Pulmonary and Respiratory Medicine 648
  • Molecular Biology 621
  • Cancer Research 528
  • Surgery 255
Replace Yoshiyasu Nakamura with:
Yoshiyasu Nakamura Japan
David Garfield United States
Yuji Sakuma Japan
Laura Boldrini Italy
Tobias Zellweger Switzerland
Madalina Tuluc United States
Kjetil Boye Norway
Iacopo Petrini Italy
Carmen Belli Italy
Haruhiro Yukiue Japan
Elaine T. Lam relative to Yoshiyasu Nakamura Japan Yoshiyasu Nakamura's profile →
Citations per field
00.5×2.6×
Yoshiyasu Nakamura · 1×
Citations per year

Countries citing papers authored by Elaine T. Lam

Since Specialization
Citations

This map shows the geographic impact of Elaine T. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaine T. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaine T. Lam more than expected).

Fields of papers citing papers by Elaine T. Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elaine T. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaine T. Lam. The network helps show where Elaine T. Lam may publish in the future.

Co-authorship network of co-authors of Elaine T. Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Elaine T. Lam. A scholar is included among the top collaborators of Elaine T. Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elaine T. Lam. Elaine T. Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 17
3 12
4 0
5 3
6 2
7 3
8 8
9 8
10 1
11 28
12 3
13 28
14 9
15 3
16 3
17 16
18 15
19 54
20 4

About Elaine T. Lam

Elaine T. Lam is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 119 papers that have together received 1.8k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (47 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Prostate Cancer Treatment and Research (19 papers). The work is most often cited by research in Cancer Research (528 citations), Oncology (677 citations) and Pulmonary and Respiratory Medicine (648 citations). Elaine T. Lam has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Thomas W. Flaig, Elizabeth R. Kessler, Brian I. Rini, Toni K. Choueiri, James Brugarolas, Ann M. Lowe, Eli M. Wallace, Jeffrey R. Infante, Robert A. Figlin and Keshi Wang. Their work appears in journals such as Journal of Clinical Oncology, Neurology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026